Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women

Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women Objective: In a seroepidemiologic study the effects of pregnancy and other factors on humoral response to human papillomavirus type 16 infection were examined. Study Design: Multiple serum samples were taken at 3-month intervals for 15 months from 77 pregnant and 85 nonpregnant women. Serologic response to human papillomavirus type 16 proteins was analyzed with a peptide-based enzyme-linked immunosorbent assay. Results: Seroreactivity was higher in nonpregnant women than in pregnant women, suggesting a reduced humoral immune response against human papillomavirus infections during pregnancy. Among the pregnant women a twofold to threefold decrease in mean reactivity in the E4 protein-based assay was detected between early gestation and delivery. The presence of human papillomavirus type 16 or 18 deoxyribonucleic acid was significantly associated with reactivity to the E6 protein ( p =0.0005) and the E4 protein ( p =0.06). Reactivity to the E4 protein also correlated with an abnormal Papanicolaou smear. Conclusions: The observation of changes in humoral response to genital human papillomavirus infections during pregnancy warrants further investigation with highly seroreactive assays. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Obstetrics and Gynecology Wolters Kluwer Health

Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women

5 pages

Loading next page...
 
/lp/wolters-kluwer-health/serologic-response-to-the-e4-e6-and-e7-proteins-of-human-yaSqKcmWA2

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 1998 Mosby, Inc.
ISSN
0002-9378
DOI
10.1016/S0002-9378(98)80026-4
Publisher site
See Article on Publisher Site

Abstract

Objective: In a seroepidemiologic study the effects of pregnancy and other factors on humoral response to human papillomavirus type 16 infection were examined. Study Design: Multiple serum samples were taken at 3-month intervals for 15 months from 77 pregnant and 85 nonpregnant women. Serologic response to human papillomavirus type 16 proteins was analyzed with a peptide-based enzyme-linked immunosorbent assay. Results: Seroreactivity was higher in nonpregnant women than in pregnant women, suggesting a reduced humoral immune response against human papillomavirus infections during pregnancy. Among the pregnant women a twofold to threefold decrease in mean reactivity in the E4 protein-based assay was detected between early gestation and delivery. The presence of human papillomavirus type 16 or 18 deoxyribonucleic acid was significantly associated with reactivity to the E6 protein ( p =0.0005) and the E4 protein ( p =0.06). Reactivity to the E4 protein also correlated with an abnormal Papanicolaou smear. Conclusions: The observation of changes in humoral response to genital human papillomavirus infections during pregnancy warrants further investigation with highly seroreactive assays.

Journal

American Journal of Obstetrics and GynecologyWolters Kluwer Health

Published: Feb 1, 1998

References